Dorchester Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-473
Closed -$290K 160
2022
Q1
$290K Buy
+473
New +$216K 0.05% 134

Other funds holding ELV

Dorchester Wealth Management's ELV Position: Q2 2022 in Review

Dorchester Wealth Management sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 473 shares — an estimated $290K sold.

Dorchester Wealth Management first reported a position in ELV in Q1 2022 and held it in 1 quarter. The position peaked at $290K in Q1 2022. 1,440 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

  • Dorchester Wealth Management reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
  • Dorchester Wealth Management sold 473 Elevance Health shares in Q2 2022, an estimated $290K.
  • Dorchester Wealth Management first reported a position in Elevance Health in Q1 2022 and held it in 1 quarter.
  • Dorchester Wealth Management's Elevance Health position peaked at $290K in Q1 2022.
  • 1,440 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Dorchester Wealth Management's 13F filing for Q2 2022, filed 4 Aug 2022.